Fildena & Planned Parenthood Ban: ED Access Hits Vulnerable Women
The recent wave of Planned Parenthood funding cuts across several U.S. states is sparking urgent debates about healthcare access, medication affordability, and gender equity. While the headlines often focus on reproductive services, the ripple effects extend far wider—impacting access to treatments like Fildena that address erectile dysfunction (ED) and related vascular conditions in women as…
